Citigroup Inc Meridian Bioscience Inc Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$31.15 - $33.39 $1.84 Million - $1.97 Million	-59,079 Reduced 51.8%	54,974 $1.83 Million
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $2.74 Million - $2.97 Million	88,644 Added 348.87%	114,053 $3.6 Million
Q2 2022 Aug 10, 2022	SELL	$23.75 - $31.69 $556,367 - $742,369	-23,426 Reduced 47.97%	25,409 $773,000
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $23,964 - $32,328	1,200 Added 2.52%	48,835 $1.27 Million
Q4 2021 Feb 10, 2022	BUY	$17.46 - $21.61 $397,057 - $491,433	22,741 Added 91.35%	47,635 $972,000
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $431,910 - $560,115	24,894 New	24,894 $479,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.